Literature DB >> 21270518

Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.

Tanya V Kalin1, Vladimir Ustiyan, Vladimir V Kalinichenko.   

Abstract

FoxM1 transcription factor (previously called HFH-11B, Trident, FoxM1b, Win, and MPP2) is expressed in actively dividing cells and critical for cell cycle progression. FoxM1 expression is induced in a variety of tissues during embryogenesis, and Foxm1 (-/-) mice exhibit embryonic lethal phenotype due to multiple abnormalities in the liver, heart, lung and blood vessels. FoxM1 levels are dramatically decreased in adult tissues, but FoxM1 expression is re-activated during organ injury and numerous cancers. In this review, we discussed the role of FoxM1 in different cell lineages using recent data from transgenic mouse models with conditional "gain-of-function" and "loss-of-function" of FoxM1, as well as tissue samples from human patients. In addition, we provided experimental data showing additional sites of FoxM1 expression in the mouse embryo. Novel cell-autonomous roles of FoxM1 in embryonic development, organ injury and cancer formation in vivo were analyzed. Potential application of these findings for the diagnosis and treatment of human diseases were discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270518      PMCID: PMC3115014          DOI: 10.4161/cc.10.3.14709

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  78 in total

1.  Increased expression of FoxM1 transcription factor in respiratory epithelium inhibits lung sacculation and causes Clara cell hyperplasia.

Authors:  I-Ching Wang; Yufang Zhang; Jonathan Snyder; Mardi J Sutherland; Michael S Burhans; John M Shannon; Hyun Jung Park; Jeffrey A Whitsett; Vladimir V Kalinichenko
Journal:  Dev Biol       Date:  2010-09-21       Impact factor: 3.582

2.  Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment.

Authors:  Nicola Brunetti-Pierri; Alex R Paciorkowski; Roberto Ciccone; Erika Della Mina; Maria Clara Bonaglia; Renato Borgatti; Christian P Schaaf; V Reid Sutton; Zhilian Xia; Naftha Jelluma; Claudia Ruivenkamp; Mary Bertrand; Thomy J L de Ravel; Parul Jayakar; Serena Belli; Katia Rocchetti; Chiara Pantaleoni; Stefano D'Arrigo; Jeff Hughes; Sau Wai Cheung; Orsetta Zuffardi; Pawel Stankiewicz
Journal:  Eur J Hum Genet       Date:  2010-08-25       Impact factor: 4.246

3.  Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis.

Authors:  David Balli; Yufang Zhang; Jonathan Snyder; Vladimir V Kalinichenko; Tanya V Kalin
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

4.  Forkhead box M1 transcription factor is required for macrophage recruitment during liver repair.

Authors:  Xiaomeng Ren; Yufang Zhang; Jonathan Snyder; Emily R Cross; Tushar A Shah; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

5.  The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.

Authors:  Satoki Nakamura; Isao Hirano; Keiji Okinaka; Tomonari Takemura; Daisuke Yokota; Takaaki Ono; Kazuyuki Shigeno; Kiyoshi Shibata; Shinya Fujisawa; Kazunori Ohnishi
Journal:  Carcinogenesis       Date:  2010-09-07       Impact factor: 4.944

6.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

7.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

8.  FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

Authors:  J Millour; D Constantinidou; A V Stavropoulou; M S C Wilson; S S Myatt; J M-M Kwok; K Sivanandan; R C Coombes; R H Medema; J Hartman; A E Lykkesfeldt; E W-F Lam
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

9.  FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of beta-catenin expression.

Authors:  Muhammad K Mirza; Ying Sun; Yidan D Zhao; Hari-Hara S K Potula; Randall S Frey; Steven M Vogel; Asrar B Malik; You-Yang Zhao
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

10.  Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells.

Authors:  Zhongqiu Xie; Guixiang Tan; Miao Ding; Difei Dong; Tuanhui Chen; Xiangxian Meng; Xiaoqin Huang; Yongjun Tan
Journal:  Nucleic Acids Res       Date:  2010-08-11       Impact factor: 16.971

View more
  108 in total

1.  Is there potential to target FOXM1 for 'undruggable' lung cancers?

Authors:  Vladimir V Kalinichenko; Tanya V Kalin
Journal:  Expert Opin Ther Targets       Date:  2015-05-04       Impact factor: 6.902

2.  FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.

Authors:  Chen Huang; Dacheng Xie; Jiujie Cui; Qi Li; Yong Gao; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-01-22       Impact factor: 12.531

Review 3.  Building and Regenerating the Lung Cell by Cell.

Authors:  Jeffrey A Whitsett; Tanya V Kalin; Yan Xu; Vladimir V Kalinichenko
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

Review 4.  FoxM1: a novel tumor biomarker of lung cancer.

Authors:  Jia Zhang; Jing Zhang; Xiaohai Cui; Ya Yang; Min Li; Jingkun Qu; Junhai Li; Jiansheng Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Forkhead box F2 regulation of platelet-derived growth factor and myocardin/serum response factor signaling is essential for intestinal development.

Authors:  Craig Bolte; Xiaomeng Ren; Tatiana Tomley; Vladimir Ustiyan; Arun Pradhan; April Hoggatt; Tanya V Kalin; B Paul Herring; Vladimir V Kalinichenko
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

6.  FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.

Authors:  Bulbul Pandit; Andrei L Gartel
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 7.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

8.  Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis.

Authors:  Hong Chen; Jingjing Wang; Hong Yang; Dan Chen; Panpan Li
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

Review 9.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

10.  FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation.

Authors:  Arunima Sengupta; Vladimir V Kalinichenko; Katherine E Yutzey
Journal:  Circ Res       Date:  2012-11-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.